4.7 Article

Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 19, Issue 7, Pages 2114-2124

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2011.02.050

Keywords

Acyclic nucleoside phosphonates; Purines; FPMP; Antiviral; N-6-Methyl-AMP aminohydrolase

Funding

  1. Institute of Organic Chemistry and Biochemistry, v.v.i. [OZ40550506]
  2. Center of new antivirals and antineoplastics [1M0508]
  3. Ministry of Education, Youth and Sports of the Czech Republic
  4. Gilead Sciences and the IOCB Research Center
  5. K.U. Leuven [GOA 10/014]

Ask authors/readers for more resources

An efficient method for the synthesis of N-9-[3-fluoro-2-(phosphonomethoxy) propyl] (FPMP) derivatives of purine bases has been developed. Both (R)- and (S)-enantiomers of the N-6-substituted FPMP derivatives of adenine and 2,6-diaminopurine were prepared and their anti-human immunodeficiency virus (HIV) and anti-Moloney murine sarcoma virus (MSV) activity was evaluated. Whereas none of the 6-substituted FPMPA derivatives showed any antiviral activity, several FPMPDAP derivatives had a moderate antiretroviral activity. Moreover, the data obtained from the study of the substrate activity of the active derivatives towards N-6-methyl-AMP aminohydrolase support the notion that the studied N-6-substituted FPMPDAP derivatives act as prodrugs of the antiretroviral FPMPG analogues. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available